Can reduced field-of-view diffusion sequence help assess microsatellite instability in FIGO stage 1 endometrial

Priya Bhosale1, Preetha Ramalingam2, Jingfei Ma3

  • 1Department of Diagnostic Radiology, University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.

Abstract

Insights

Reduced-field-of-view intravoxel incoherent motion (IVIM) MRI can differentiate microsatellite stable (MSS) from microsatellite unstable (MSI) endometrial tumors. Parameters like ADC and Dt may noninvasively determine MSI status in early-stage endometrial cancer.

Area of Science:

  • Oncology
  • Radiology
  • Biomedical Imaging

Background:

  • Endometrial cancer microsatellite instability (MSI) status impacts treatment decisions.
  • Non-invasive methods to determine MSI status are needed.

Purpose of the Study:

  • To assess if reduced-field-of-view (rFOV) diffusion intravoxel incoherent motion (IVIM) MRI can distinguish between MSI and microsatellite stable (MSS) tumors in early-stage endometrial cancer.
  • To evaluate MRI's potential for non-invasively determining MSI status.

Main Methods:

  • Sagittal rFOV diffusion-weighted images were acquired using a 3T scanner with six b-values.
  • Apparent diffusion coefficient (ADC), true diffusion coefficient (Dt), pseudodiffusion (D*), and perfusion fraction (f) were derived.
  • Regions of interest (ROIs) were analyzed for IVIM parameters and compared with microsatellite status.

Main Results:

  • Microsatellite stable (MSS) tumors showed significantly higher ADC values (P=0.03) and Dt (P=0.045) compared to microsatellite unstable (MSI) tumors.
  • No significant association was found between myometrial invasion depth and MSI status (P>0.99).

Conclusions:

  • Intravoxel incoherent motion (IVIM) parameters, including ADC and Dt, show potential for non-invasively determining microsatellite status in FIGO stage I endometrial cancer.
  • MRI may offer a non-invasive approach to assess MSI status, aiding in treatment stratification.

Related Concept Videos